# VYVGART Hytrulo

NDC: 73475-3102
Generic name: efgartigimod alfa and hyaluronidase (human recombinant)
Labeler / Manufacturer: argenx US
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20230620

FDA application: BLA761304

## Active ingredients

- EFGARTIGIMOD ALFA: 180 mg/mL
- HYALURONIDASE (HUMAN RECOMBINANT): 2000 U/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"73475-3102"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=73475-3102
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7104d9e5-9910-47f5-9a93-741ac50f43b6